ZIVO Bioscience, Inc. (ZIVO)
OTCMKTS
· Delayed Price · Currency is USD
3.650
-0.670 (-15.51%)
Jun 26, 2026, 4:00 PM EST
ZIVO Bioscience Employees
ZIVO Bioscience had 7 employees as of December 31, 2024. The number of employees decreased by 1 or -12.50% compared to the previous year.
Employees
7
Change (1Y)
-1
Growth (1Y)
-12.50%
Revenue / Employee
$29,861
Profits / Employee
-$1,212,266
Market Cap
18.68M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Inhibitor Therapeutics | 8 |
| Zeo ScientifiX | 20 |
| Galera Therapeutics | 3 |
| Adaptimmune Therapeutics | 506 |
| Anebulo Pharmaceuticals | 3 |
| Brainstorm Cell Therapeutics | 19 |
ZIVO Bioscience News
- 6 weeks ago - Zivo Bioscience announces transition to OTCID marketplace - TheFly
- 6 weeks ago - Zivo Bioscience, Inc. Announces Transition to OTCID Marketplace - Business Wire
- 3 months ago - Zivo Bioscience secures manufacturing agreement with Cyanotech - TheFly
- 3 months ago - ZIVO Bioscience Provides Special Letter to Shareholders - Business Wire
- 10 months ago - ZIVO Bioscience CEO Letter to Shareholders Highlights Progress with Human Nutrition and Animal Therapeutic Businesses - Business Wire
- 1 year ago - ZIVO Bioscience and Leading Global Animal Health Company to Advance ZIVO's Immune-Enhancing Compounds in Poultry - Business Wire
- 1 year ago - University of Delaware Study Identifies Optimal Formulation of ZIVO's Active Ingredients for Further Testing to Mitigate Avian Influenza in Poultry - Business Wire
- 1 year ago - ZIVO Bioscience Plans New Study with University of Delaware to Combat Avian Influenza in Poultry - Business Wire